These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. NAFLD-related hepatocellular carcinoma: The growing challenge. Shah PA; Patil R; Harrison SA Hepatology; 2023 Jan; 77(1):323-338. PubMed ID: 35478412 [TBL] [Abstract][Full Text] [Related]
13. The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis. Tobari M; Hashimoto E; Taniai M; Kodama K; Kogiso T; Tokushige K; Yamamoto M; Takayoshi N; Satoshi K; Tatsuo A J Gastroenterol Hepatol; 2020 May; 35(5):862-869. PubMed ID: 31597206 [TBL] [Abstract][Full Text] [Related]
14. From NASH to HCC: current concepts and future challenges. Anstee QM; Reeves HL; Kotsiliti E; Govaere O; Heikenwalder M Nat Rev Gastroenterol Hepatol; 2019 Jul; 16(7):411-428. PubMed ID: 31028350 [TBL] [Abstract][Full Text] [Related]
15. The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives. Pennisi G; Celsa C; Giammanco A; Spatola F; Petta S Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717576 [TBL] [Abstract][Full Text] [Related]
16. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Perumpail RB; Wong RJ; Ahmed A; Harrison SA Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831 [TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
19. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Bertot LC; Adams LA Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782 [TBL] [Abstract][Full Text] [Related]
20. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Huang DQ; El-Serag HB; Loomba R Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]